Skip to main content
. 2017 Jun 23;6(3):325–328. doi: 10.1016/j.imr.2017.06.002

Table 1.

Body weight and serum hormone levels throughout the treatment course.

Variable April 2015 May 2016 October 2016
Body weight (kg) 88.2 67.0 66.0
BMI (kg/m2) 33.9 25.7 25.3
FSH (mIU/mL) 5.67 4.53 4.33
LH (mIU/mL) 14.61 2.74 3.09
E2 (pg/mL) 28.15 33.15 8.13
Testosterone (ng/mL) 1.43 1.01 0.81
DHEA-S (μg/dL) 1024.4 736.2 542.9
SHBG (nmol/L) 10 21.1 30.8
AMH (ng/mL) 5.91 5.56 3.77
Total cholesterol (mg/dL) 159 128 143
HDL cholesterol (mg/dL) 53 54 60
LDL cholesterol (mg/dL) 89 67 75
AST (IU/L) 24 18 13
ALT (IU/L) 22 8 8
Creatinine (mg/dL) 0.9 0.8 0.8

AMH, antimullerian hormone; ALT, alanine transminase; AST, asparte transminase; BMI, body mass index; DHEA-S, dehydroepiandrosterone sulfate; E2, estradiol; FSH, follicular stimulating hormone; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LH, luteinizing hormone; SHBG, sex hormone binding globulin.